OS Therapies (OSTX)
NYSE: OSTX
· Real-Time Price · USD
2.08
0.02 (0.97%)
At close: Aug 18, 2025, 10:56 AM
OS Therapies Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -2.99M | -2.88M | -1.56M | -1.46M | -1.46M | -1.97M | -2.51M | -1.85M | -2.55M | -1.36M | -2.36M |
Depreciation & Amortization | 1.39K | 338.29K | 695.00 | 695.00 | 213.24K | 3.31K | 836.73K | 616.25K | 626.32K | 249.09K | 885.78K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 345.84K | 65.05K | 316.43K | 196.38K | 148.9K | 255.29K | 25.65K | 239.81K | 118.87K | 186.16K | 215.37K |
Other Non-Cash Items | 379.32K | -897.53K | 446.53K | 578.74K | 213.24K | 981.14K | 811.63K | 562.72K | 283.83K | -33.64K | 577.79K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 235.94K | -832.48K | 229.07K | 237.83K | 148.9K | 113.96K | 25.65K | 239.81K | 118.87K | 186.16K | 215.37K |
Operating Cash Flow | -2.37M | -3.38M | -881.19K | -641.73K | -871.16K | -876.57K | -831.05K | -428.19K | -1.52M | -960.91K | -681.62K |
Capital Expenditures | n/a | n/a | n/a | n/a | 19.00 | n/a | -19 | n/a | n/a | n/a | -7.1K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 19.00 | n/a | n/a | 1.15K | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | 19.00 | n/a | -19 | 1.15K | n/a | n/a | -7.1K |
Debt Repayment | n/a | -250K | 900K | 851K | 1.07M | 825K | 487.5K | 775K | 1.89M | 885K | 555.63K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 6.05M | 5.4M | -24.11K | -148.02K | -175.94K | 18.41K | 37.58K | -164.22K | -237.02K | 40K | 50K |
Financial Cash Flow | 6.05M | 5.15M | 875.88K | 702.98K | 894.06K | 843.41K | 525.08K | 610.77K | 1.66M | 925K | 605.63K |
Net Cash Flow | 3.68M | 1.76M | -5.31K | 61.25K | 22.92K | -33.16K | -305.99K | 183.73K | 171.48K | -35.91K | 80.79K |
Free Cash Flow | -2.37M | -3.38M | -881.19K | -641.73K | -871.14K | -876.57K | -831.07K | -428.19K | -1.52M | -960.91K | -688.72K |